Aug. 2, 2012—More than 100 students, faculty and scientists from around the world attended a four-day program on vascular biology research last week at Vanderbilt University.
Aug. 2, 2012—Researchers in the Vanderbilt Flow Cytometry Shared Resource (FCSR) show off the new Amnis FlowSight, which provides an image of every single cell that passes through it and merges the capabilities of flow cytometry and fluorescent microscopy. From left are David Flaherty, lab manager, Kevin Weller, FCSR managing director, Core Research Assistant I Chris Warren...
Jul. 31, 2012—A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.
Jul. 30, 2012—The Vanderbilt Kennedy Center’s Fragile X Treatment Research Program will present information and current research on fragile X at a symposium titled “Transitions and Adulthood.” The free event is Monday, Aug. 20, at 6:30 p.m. at the Holiday Inn Nashville-Vanderbilt and is open to family members, friends, researchers, clinicians, students, community professionals and disability advocates....
Jul. 30, 2012—Hot and humid temperatures across the Southeast may have people feeling lethargic, but conditions are perfect for active ticks and mosquitos. Insects are out in abundance and reaping the benefits from a mild winter and an early spring. As a result, pediatricians with the Monroe Carell Jr. Children’s Hospital at Vanderbilt are experiencing a significant...
Jul. 26, 2012—Officially established on April 1, Vanderbilt’s new Department of Physical Medicine and Rehabilitation (PM&R) has welcomed its first new faculty recruit and is establishing clinical and research programs.
Jul. 26, 2012—A California high school student helped accelerate an anti-obesity drug discovery program at Vanderbilt University this summer — and provided the proof-of-principle for a new technique that could save the lab an estimated $250,000 in the process.
Jul. 26, 2012—An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.
Jul. 26, 2012—Three students in Vanderbilt University School of Nursing’s Master of Science in Nursing program and three rising fourth-year Vanderbilt University School of Medicine students have been selected as 2012 Frist Global Health Leaders.